TOKYO -- The general public in Japan will be able to receive low-cost at-home coronavirus testing from SoftBank Group, which until now had only offered its PCR screening to companies and local governments.
Saliva-based polymerase chain reaction tests will be available to asymptomatic people beginning in March for an expected cost of 2,200 yen ($21), including taxes but excluding shipping and other costs -- the same price SoftBank charges to corporate and public-sector users.
